Clinical trial
Comparative Effectiveness of Biologics or Small Molecule Therapies After Failure of Anti-TNF Treatment in Patients With Crohn's Disease and Ulcerative Colitis
NCT04852666 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Effectiveness of Biologics or Small Molecule Therapies After Failure of Anti-TNF Treatment in Patients With Crohn's Disease and Ulcerative Colitis
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 25, 2019
- Completion date
- December 15, 2022
- Enrollment
- 465 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease, ulcerative colitis